5th Emerging Frontiers in Oncology Summit

Greenberg Traurig is a sponsor of the 5th Emerging Frontiers in Oncology Summit on May 18 in Boston. The summit will focus on new modalities beyond cell therapy for oncology and the drivers of future breakthroughs in oncology across research, innovation, and people. The summit will also discuss what is required to improve the translation of the future oncology pipeline.  Greenberg Traurig Shareholder Prashant Girinath, Ph.D. will moderate the innovation debate-style panel "Where is the problem - Implementation vs. Innovation."